Objective Sleep Duration is Associated with Cognitive Deficits in Primary Insomnia: BDNF May Play a Role.

Teng-Teng Fan,Wen-Hao Chen,Le Shi,Xiao Lin,Serik Tabarak,Si-Jing Chen,Jian-Yu Que,Yan-ping Bao,Xiang-Dong Tang,Jie Shi,Lin Lu,Hong-Qiang Sun,Jia
DOI: https://doi.org/10.1093/sleep/zsy192
IF: 6.313
2018-01-01
SLEEP
Abstract:Study Objectives: Objective sleep duration has been linked to insomnia severity. However, cognitive functions of people with insomnia with different sleep durations have been seldom addressed. Brain-derived neurotrophic factor (BDNF) has an important role in cognitive function and has been linked to clinical insomnia recently. The present study aimed to evaluate the comprehensive cognitive functions in people with primary insomnia with different objective sleep durations, and further examine the involvement of peripheral BDNF. Methods: Fifty-seven people with insomnia were subdivided into short sleep duration (SSD, sleep time <6 hr) group and normal sleep duration (NSD, sleep time >= 6 hr) group based on polysomnography data. Twenty-nine healthy controls (HC) were matched on age, gender, and education. Cognitive function was assessed using a comprehensive and sensitive neuropsychological test battery. Both objective and subjective insomnia statuses were estimated. Serum BDNF level was measured using enzyme-linked immune sorbent assay. Results: Compared with HC, the SSD group showed impaired neuropsychological performances in spatial span, brief visuospatial memory test, fluency, managing emotions, and continuous performance tests. In contrast, NSD had bad performance only in brief visuospatial memory test and continuous performance tests, and relatively better than SSD group in the latter test. People with SSD insomnia but not NSD had decreased BDNF levels compared with HC, and neuropsychological performance was positively correlated with BDNF levels only in SSD group. Conclusions: Primary insomnia was associated with impaired neuropsychological performance, and the impairment might be related to decreased objective sleep duration. In addition, decreased peripheral BDNF might mediate the impaired cognitive functions of people with insomnia with SSD. Statement of Significance This is the first study addressing the role of brain-derived neurotrophic factor (BDNF) in cognitive functions of people with primary insomnia. We found that people with insomnia with short sleep duration had worse cognitive performance than people with insomnia with normal sleep duration. Our present study added evidence to previous findings that insomnia with short sleep duration is a biologically severer type of insomnia and could predict worse medical conditions. We also suggested that peripheral BDNF levels could be considered as a biomarker of objective insomnia and contribute to the impaired cognitive performance. We therefore speculate that insomnia as a chronic stressor leads to decreased BDNF levels, which in turn result in cognitive dysfunction. Further prospective studies with larger sample size are needed.
What problem does this paper attempt to address?